CAS 15982-84-0

Formule : C22H23NO

InChI : InChI=1S/C22H23NO/c24-22-19-14-8-7-13-18(19)21(23-17-11-5-2-6-12-17)20(22)15-16-9-3-1-4-10-16/h1,3-4,7-10,13-15,17,21,23H,2,5-6,11-12H2/b20-15-

Code InChI : XJDKPLZUXCIMIS-HKWRFOASSA-N

SMILES : C1CCC(CC1)NC\2C3=CC=CC=C3C(=O)/C2=C\C4=CC=CC=C4

(E/Z)-BCI

CAS : 15982-84-0

(E/Z)-BCI (NSC-150117), a dual-specificity phosphatase 6 (DUSP6) inhibitor with anti-inflammatory properties, reduces LPS-induced inflammatory mediators and ROS

Formule : C₂₂H₂₃NO

Degré de pureté : 99.94%

Couleur et forme : White Solid

Masse moléculaire : 317.4241

Ref: TM-T11139

BCI

CAS : 15982-84-0

BCI

Degré de pureté : 98%

Masse moléculaire : 317.42g/mol

Ref: 54-BISN0086

(E/Z)-BCI

CAS : 15982-84-0

(E/Z)-BCI

Formule : C₂₂H₂₃NO

Degré de pureté : ≥98%

Masse moléculaire : 317.42

Ref: 54-BUP12860

(E/Z)-BCI

CAS : 15982-84-0

Formule : C₂₂H₂₃NO

Degré de pureté : 98%

Masse moléculaire : 317.4241

Ref: IN-DA01JK72

(E/Z)-BCI

CAS : 15982-84-0

(E/Z)-BCI is a medicinal compound that has shown potential as an inhibitor of cancer cell growth. It has been studied for its ability to induce apoptosis, or programmed cell death, in human tumor cells. (E/Z)-BCI is an inhibitor of the kinase protein, which plays a key role in regulating cell division and proliferation. In preclinical studies, this compound has been shown to inhibit the growth of cancer cells in various cell lines, including Chinese hamster ovary cells and leukemia cells. The analog of (E/Z)-BCI has also been detected in human urine samples, suggesting its potential as a therapeutic agent for cancer treatment.

Formule : C₂₂H₂₃NO

Degré de pureté : Min. 95%

Masse moléculaire : 317.4 g/mol

Ref: 3D-QAA98284